Citation Tools

Download PDFPDF
Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia

Download to a citation manager

Cite this article as:
Issa PC, Finger RP, Holz FG, et al
Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia